# PEX010-Assisted Therapy for Opioid Use Disorder (OUD): a Feasibility Study

> **NCT06608459** · PHASE2 · NOT_YET_RECRUITING · sponsor: **Filament Health Corp.** · enrollment: 10 (estimated)

## Conditions studied

- Opioid Use Disorder

## Interventions

- **DRUG:** PEX010-Assisted Therapy

## Key facts

- **NCT ID:** NCT06608459
- **Lead sponsor:** Filament Health Corp.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2024-12
- **Primary completion:** 2026-12
- **Final completion:** 2027-06
- **Target enrollment:** 10 (ESTIMATED)
- **Last updated:** 2024-10-17

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06608459

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06608459, "PEX010-Assisted Therapy for Opioid Use Disorder (OUD): a Feasibility Study". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT06608459. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*